MENU
+Compare
IXJ
ETF ticker: NYSE ARCA
AS OF
Jul 25 closing price
Price
$87.47
Change
+$0.34 (+0.39%)
Net Assets
3.8B

IXJ stock forecast, quote, news & analysis

The investment seeks to track the S&P Global 1200 Health Care IndexTM... Show more

Category: #Health
IXJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for IXJ with price predictions
Jul 25, 2025

IXJ in upward trend: price may jump up because it broke its lower Bollinger Band on July 18, 2025

IXJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where IXJ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on IXJ as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IXJ just turned positive on July 24, 2025. Looking at past instances where IXJ's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

IXJ moved above its 50-day moving average on July 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IXJ advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXJ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to track the S&P Global 1200 Health Care IndexTM. The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets.

Market Cap

The average market capitalization across the iShares Global Healthcare ETF ETF is 85.11B. The market cap for tickers in the group ranges from 64.65K to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the iShares Global Healthcare ETF ETF was 4%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was -2%. WST experienced the highest price growth at 25%, while MOH experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the iShares Global Healthcare ETF ETF was 8%. For the same stocks of the ETF, the average monthly volume growth was 38% and the average quarterly volume growth was 36%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 49
P/E Growth Rating: 65
Price Growth Rating: 51
SMR Rating: 56
Profit Risk Rating: 63
Seasonality Score: 12 (-100 ... +100)
View a ticker or compare two or three
IXJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com